Vincent Vuaroqueaux
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
High In Vitro and In Vivo Activity of BI-847325, a Dual MEK/Aurora Kinase Inhibitor, in Human Solid and Hematologic Cancer Models.
Journal: Cancer research communications
Published: January 30, 2023
Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical Prostatectomy.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: November 23, 2022
Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival.
Journal: Cancers
Published: February 21, 2022
Author Correction: Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma.
Journal: Communications biology
Published: July 26, 2020
Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma.
Journal: Communications biology
Published: November 20, 2019
MET-GRB2 Signaling-Associated Complexes Correlate with Oncogenic MET Signaling and Sensitivity to MET Kinase Inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 30, 2016
Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 03, 2014
Predictive gene signatures for bevacizumab and cetuximab as well as cytotoxic agents.
Journal: International journal of clinical pharmacology and therapeutics
Published: December 24, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026